Brind.

ESC and EAS guidelines validate the clinical benefit of bempedoic acid, and Daiichi Sankyo is named the European partner for Esperion.

1 report, 1 independent Updated Aug 29
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

ESC and EAS guidelines validate the clinical benefit of bempedoic acid, and Daiichi Sankyo is named the European partner for Esperion.

Who's involved

What this event is mainly about
European Society of Cardiology

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireEsperion’s Bempedoic Acid Receives Level 1a Recommendation in Updated ESC/EAS Guidelines for Management of Dyslipidaemias – Bempedoic Acid Receives Strongest Endorsement from ESC/EAS Guidelines Based